September 2012

Date Archive

The Australian media is currently afire with “he-said, she-said” accounts of the recent industrial dispute between the construction company, Grocon and the Construction Forestry, Mining and Energy Union (CFMEU).

For nearly three weeks, the CFMEU and its members blockaded the construction site of a major development in the heart of Melbourne’s central business district.


At the beginning of each semester at Monash University I conduct an ice-breaker activity with my CSR students where I ask them to list companies they consider to be Good vs. Evil.

I use the exercise to stimulate the students’ thinking about what it means for a company to be sustainable and to challenge long-held assumptions.


Big pharma companies should innovate more.

Well, who shouldn’t?

Still, they must do so urgently, according to a recent report from McKinsey – manufacturing technology has become very inefficient, which leads to too high production costs, which contribute to outstandingly diminishing marginal returns on investment, which might lead to business feasibility risks in the near future.